Late toxicity of proton beam therapy for patients with the nasal cavity, para-nasal sinuses, or involving the skull base malignancy: importance of long-term follow-up

International Journal of Clinical Oncology

Volumn 20, Issue 3, 2015, Pages 447-454

  Zenda, Sadamoto ^a   Kawashima, Mitsuhiko ^a   Arahira, Satoko ^a   Kohno, Ryosuke ^a   Nishio, Teiji ^a   Tahara, Makoto ^a   Hayashi, Ryuichi ^a   Akimoto, Tetsuo ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

Follow up; Head and neck cancer; Late toxicity; Proton beam therapy

Indexed keywords

CISPLATIN;

ADENOID CYSTIC CARCINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; BONE NECROSIS; BRAIN NECROSIS; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CATARACT; CAUSE OF DEATH; ENCEPHALOMYELITIS; ESTHESIONEUROBLASTOMA; FEMALE; FOLLOW UP; HEARING IMPAIRMENT; HUMAN; INDUCTION CHEMOTHERAPY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MELANOMA; MUCOSAL MELANOMA; MULTIMODALITY CANCER THERAPY; NOSE CAVITY TUMOR; OPTIC NERVE DISEASE; OVERALL SURVIVAL; PARANASAL SINUS TUMOR; PATIENT SATISFACTION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTON THERAPY; RADIATION DOSE; RADIATION INJURY; RETROSPECTIVE STUDY; SKULL BASE TUMOR; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; TISSUE NECROSIS; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR VOLUME; VISUAL ACUITY; ADVERSE EFFECTS; MIDDLE AGED; NOSE CAVITY; NOSE NEOPLASMS; PARANASAL SINUS NEOPLASMS; SKULL BASE NEOPLASMS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NASAL CAVITY; NOSE NEOPLASMS; PARANASAL SINUS NEOPLASMS; PROTON THERAPY; RETROSPECTIVE STUDIES; SKULL BASE NEOPLASMS; YOUNG ADULT;

EID: 84930570767     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-014-0737-8     Document Type: Article

References (20)

1. Ketcham AS, Wilkins RH, Vanburen JM, Vanburen JM, Smith RR (1963) A combined intracranial facial approach to the paranasal sinuses. Am J Surg 106:698–703
2. Blanco AI, Chao KS, Ozyigit G et al (2004) Carcinoma of paranasal sinuses: long-term outcomes with radiotherapy. Int J Radiat Oncol Biol Phys 59(1):51–58
3. Hoppe BS, Stegman LD, Zelefsky MJ et al (2007) Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting: the MSKCC experience. Int J Radiat Oncol Biol Phys 67(3):691–702
4. Jansen EP, Keus RB, Hilgers FJ, Haas RL, Tan IB, Bartelink H (2000) Does the combination of radiotherapy and debulking surgery favor survival in paranasal sinus carcinoma? Int J Radiat Oncol Biol Phys 48(1):27–35
5. Dulguerov P, Jacobsen MS, Allal AS, Lehmann W, Calcaterra T (2001) Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. Cancer (Phila) 92(12):3012–3029
6. Snyers A, Janssens GO, Twickler MB et al (2009) Malignant tumors of the nasal cavity and paranasal sinuses: long-term outcome and morbidity with emphasis on hypothalamic-pituitary deficiency. Int J Radiat Oncol Biol Phys 73(5):1343–1351
7. Dirix P, Nuyts S, Geussens Y et al (2007) Malignancies of the nasal cavity and paranasal sinuses: long-term outcome with conventional or three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 69(4):1042–1050
8. Hoppe BS, Nelson CJ, Gomez DR et al (2008) Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities. Int J Radiat Oncol Biol Phys 72(3):763–769
9. Nutting CM, Morden JP, Harrington KJ et al (2011) Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 12(2):127–136
10. Zenda S, Kohno R, Kawashima M et al (2011) Proton beam therapy for unresectable malignancies of the nasal cavity and paranasal sinuses. Int J Radiat Oncol Biol Phys 81(5):1473–1478
11. Nishimura H, Ogino T, Kawashima M et al (2007) Proton-beam therapy for olfactory neuroblastoma. Int J Radiat Oncol Biol Phys 68(3):758–762
12. Fuji H, Nakasu Y, Ishida Y et al (2011) Feasibility of proton beam therapy for chordoma and chondrosarcoma of the skull base. Skull Base 21(3):201–206
13. Debus J, Wuendrich M, Pirzkall A et al (2001) High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: long-term results. J Clin Oncol 19(15):3547–3553
14. Lee DS, Kim YS, Cheon JS et al (2012) Long-term outcome and toxicity of hypofractionated stereotactic body radiotherapy as a boost treatment for head and neck cancer: the importance of boost volume assessment. Radiat Oncol 7:85
15. Mizoe JE, Hasegawa A, Jingu K et al (2012) Results of carbon ion radiotherapy for head and neck cancer. Radiother Oncol 103(1):32–37
16. Stelzer KJ (2000) Acute and long-term complications of therapeutic radiation for skull base tumors. Neurosurg Clin N Am 11(4):597–604
17. Sheline GE, Wara WM, Smith V (1980) Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys 6(9):1215–1228
18. Marks JE, Baglan RJ, Prassad SC, Blank WF (1981) Cerebral radionecrosis: incidence and risk in relation to dose, time, fractionation and volume. Int J Radiat Oncol Biol Phys 7(2):243–252
19. Woo E, Lam K, Yu YL, Lee PW, Huang CY (1987) Cerebral radionecrosis: is surgery necessary? J Neurol Neurosurg Psychiatry 50(11):1407–1414
20. Hotta K, Kohno R, Takada Y et al (2010) Improved dose-calculation accuracy in proton treatment planning using a simplified Monte Carlo method verified with three-dimensional measurements in an anthropomorphic phantom. Phys Med Biol 55(12):3545–3556